Breaking News Instant updates and real-time market news.

CFG

Citizens Financial

$25.70

0.13 (0.51%)

, KEY

KeyCorp

$12.74

-0.025 (-0.20%)

16:14
10/06/16
10/06
16:14
10/06/16
16:14

Citizens Financial initiated with an Outperform at Wedbush

Wedbush analyst Peter Winter initiated coverage of 14 regional and Texas banks, starting Citizens Financial (CFG) with an Outperform rating. The other three banks on which Winter assigned an Outperform rating are KeyCorp (KEY), Huntington Bancshares (HBAN) and Regions Financial (RF).

CFG

Citizens Financial

$25.70

0.13 (0.51%)

KEY

KeyCorp

$12.74

-0.025 (-0.20%)

HBAN

Huntington Bancshares

$10.16

0.02 (0.20%)

RF

Regions Financial

$10.33

0.015 (0.15%)

  • 21

    Oct

  • 25

    Oct

  • 26

    Oct

  • 16

    Nov

CFG Citizens Financial
$25.70

0.13 (0.51%)

05/13/16
WELS
05/13/16
UPGRADE
WELS
Outperform
Citizens Financial upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Matthew Burnell upgraded Citizens Financial to Outperform saying the market is dismissing the company's fundamental improvements. The analyst adds that Citizens has above-peer leverage should rates rise faster than anticipated. Burnell raised his price target range for the shares to $24-$26 from $23-$25.
05/31/16
RBCM
05/31/16
NO CHANGE
RBCM
Interest rate hikes to boost bank earnings, says RBC Capital
RBC Capital predicts that the Fed will hike interest rates two more times this year, with the first increase coming midyear and the second at the end of the year. The firm believes that the increases will boost bank earnings. The firm believes that the following banks could benefit the most from a rising interest rate environment: Bank of America (BAC), Citizens Financial (CFG), Comerica (CMA), JPMOrgan (JPM), M&T Bank (MTB), Regions Financial (RF), and Zions Bancorporation (ZION).
08/02/16
BOFA
08/02/16
NO CHANGE
Target $25
BOFA
Buy
Citizens Financial turnaround story underappreciated, says BofA/Merrill
BofA/Merrill analyst Erika Najarian reiteated his Buy rating on Citizens Financial following investor meetings with Chairm and CEO Bruce van Saun. The analyst believes Citizens is the only real turnaround story left and can produce 10% earnings growth in 2017, without the help from interest rates, and continues to trade at the steepest discount to TBV versus peers. van Saun said shares are under-owned and reiterates his Buy rating.
01/22/16
PIPR
01/22/16
NO CHANGE
PIPR
Overweight
Apple iPhone upgrade program off to stable start, says Piper Jaffray
Piper Jaffray analyst Gene Munster noted that Citizen's Financial (CFG), Apple's (AAPL) financing partner for the iPhone upgrade program, reported that it had $220M in iPhone loans at the end of the year. That balance implies that Apple sold about 250,000 iPhones on the program since the iPhone 6S launch, said Munster, adding that he views this as a "stable start" for the program. Munster, who continues to think that program will help shrink the iPhone upgrade cycle in the U.S., keeps an Overweight rating and $179 price target on Apple shares.
KEY KeyCorp
$12.74

-0.025 (-0.20%)

07/25/16
JPMS
07/25/16
INITIATION
Target $14
JPMS
Overweight
KeyCorp reinstated with an Overweight at JPMorgan
JPMorgan analyst Steven Alexopoulos reinstated KeyCorp with an Overweight rating and $14 price target. The rating is unchanged and the price target is lowered from $15 from the analyst's previous coverage.
07/25/16
07/25/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Allergan (AGN) initiated with an Outperform at Credit Suisse. 2. VMware (VMW) initiated with an Overweight at Morgan Stanley. 3. Syros Pharmaceuticals (SYRS) initiated with an Overweight at Piper Jaffray, an Outperform at JMP Securities, an Outperform at Cowen, and an Outperform at Wedbush. 4. Level 3 (LVLT) initiated with a Sector Weight at Pacific Crest. 5. KeyCorp (KEY) reinstated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/05/16
10/05/16
DOWNGRADE

Equal Weight
Fifth Third downgraded to Equal Weight at Stephens
As previously reported, Stephens analyst Terry McEvoy downgraded Fifth Third (FITB) to Equal Weight from Overweight on valuation. The analyst now sees the underlying value and capital flexibility from the company's investment in Vantiv (VNTV) as being largely reflected in the stock's valuation and have more comfort in future expense trends. Given the outperformance at Fifth Third, McEvoy believes investors should take profits and move into KeyCorp (KEY).
08/29/16
PIPR
08/29/16
DOWNGRADE
Target $13
PIPR
Neutral
KeyCorp downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Kevin Barker downgraded KeyCorp to Neutral saying expectations are too high heading into the "noisy" second half of the year. The analyst lowered his price target for the shares to $13 from $14.50. The shares will have a difficult time outperforming peers as estimates continue to move lower over the next several months, Barker tells investors in a research note.
HBAN Huntington Bancshares
$10.16

0.02 (0.20%)

07/11/16
FBRC
07/11/16
UPGRADE
Target $11
FBRC
Outperform
Huntington Bancshares upgraded to Outperform from Market Perform at FBR Capital
FBR Capital analyst Paul Miller upgraded Huntington Bancshares to Outperform saying he likes the risk/reward profile at current valuation levels. The stock, near multiyear lows, is pricing in poor sentiment and disappointment with the company's capital plan, Miller tells investors in a research note. He keeps an $11 price target for the shares.
06/27/16
RBCM
06/27/16
NO CHANGE
RBCM
Some banks have reached attractive entry points, says RBC Capital
RBC Capital believes that banks may be hurt by the Fed's decision to delay raising interest rates in the wake of Brexit, and the firm admits that ucertainty regarding the EU membership of other countries could hurt U.S. banks going forward. However, the firm adds that "a silver lining" could be a boost to banks' fixed income businesses. Additionally, the firm thinks that the 10% decline in the shares of some banks "seems to be a bit premature," with the valuation of a number of banks falling to "low levels." It recommends that investors buy the following bank stocks: lBB&T (BBT), Huntington Bancshares (HBAN), JPMorgan (JPM), KeyCorp (KEY), M&T Bank (MTB), Northern Trust (NTRS), PNC Financial (PNC) and U.S. Bancorp (USB). The firm adds that "risk oriented investors should look to buy" Bank of America (BAC) and Citi (C).
09/28/16
09/28/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Workday (WDAY) upgraded to Neutral from Underperform at Wedbush with analyst Steve Koenig citing second-half 2016 sales potential, following a first-half which he thinks wasn't as good as generally perceived. 2. Dillard's (DDS) upgraded to Outperform from Neutral at Credit Suisse with analyst Michael Exstein citing the company's consistency in capital allocation and its valuation, which he says is at the low end of its historic trading range. 3. Cypress Energy (CELP) upgraded to Buy from Hold at Stifel analyst Michael Hoffman saying the CEO is upbeat on the company's outlook and its ability to maintain its distribution at current levels. 4. Huntington Bancshares (HBAN) upgraded to Buy from Hold at Deutsche Bank with analyst Matt O'Connor saying the 15% pullback in the shares since the FirstMerit (FMER) deal was announced is overdone. 5. Hi-Crush Partners (HCLP) upgraded to Neutral from Sell at UBS with analyst Shneur Gershuni saying recent commentary from oil field service companies indicate an increase in sand demand and intensity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/28/16
DBAB
09/28/16
UPGRADE
Target $11.5
DBAB
Buy
Huntington Bancshares upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Matt O'Connor upgraded Huntington Bancshares to Buy saying the 15% pullback in the shares since the FirstMerit (FMER) deal was announced is overdone. The analyst views industry-wide concerns surrounding consumer indirect auto lending as overblown and he raised his price target for Huntington shares to $11.50 from $10.50. Going into the Q3 results for U.S. banks, O'Connor likes JPMorgan (JPM) and Wells Fargo (WFC) and is cautious on Fifth Third (FITB).
RF Regions Financial
$10.33

0.015 (0.15%)

10/06/16
RAJA
10/06/16
DOWNGRADE
RAJA
Outperform
Regions Financial downgraded to Outperform from Strong Buy at Raymond James
Raymond James analyst David Long downgraded Regions Financial to Outperform due to strong share performance and maintained its $10.50 price target.
08/16/16
08/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hain Celestial (HAIN) downgraded to Equal Weight from Overweight at Barclays, to Neutral from Buy at SunTrust, to Underweight from Neutral at Piper Jaffray, and to Underweight from Neutral at Atlantic Equities. 2. JPMorgan (JPM), SunTrust (STI), and Regions Financial (RF) downgraded to Market Perform from Outperform at Bernstein. 3. Performance Sports Group (PSG) downgraded to Neutral from Outperform at Wedbush with analyst James Hardiman saying the delay in the filing of the company's 10-K could cause it to default. 4. Ocean Rig UDW (ORIG) downgraded to Hold from Buy at Deutsche Bank with analyst Mike Urban saying the company's restructuring is likely unfavorable for existing equity holders. 5. Alarm.com (ALRM) downgraded to Market Perform from Outperform at Raymond James with the firm citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/16/16
BERN
08/16/16
DOWNGRADE
BERN
Market Perform
Regions Financial downgraded based on valuation at Bernstein
As noted earlier, Bernstein downgraded Regions to Market Perform from Outperform. Analyst John McDonald downgraded the stock based on valuation. Additionally, the analyst says that banks will be hurt by an eventual downturn in credit metrics, while expectations of interest rate increases have diminished. Target remains $9.50.
08/16/16
BERN
08/16/16
DOWNGRADE
BERN
Market Perform
Regions Financial downgraded to Market Perform from Outperform at Bernstein

TODAY'S FREE FLY STORIES

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

, BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

17:41
04/23/17
04/23
17:41
04/23/17
17:41
Earnings
C.R. Bard reports Q1 adjusted EPS $2.87, consensus $2.65 »

Reports Q1 revenue…

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

, BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

17:38
04/23/17
04/23
17:38
04/23/17
17:38
Hot Stocks
Becton Dickinson names Polen as president, says will lead Bard segment »

BD (BDX) announced the…

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

HCMLY

LafargeHolcim

$11.56

-0.1 (-0.86%)

17:32
04/23/17
04/23
17:32
04/23/17
17:32
Periodicals
LafargeHolcim CEO set to step down, FT reports »

LafargeHolcim CEO Eric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

, BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

17:30
04/23/17
04/23
17:30
04/23/17
17:30
Hot Stocks
Becton Dickinson outlines strategic highlights of C.R. Bard acquisition »

Expanding on the…

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

KLRE

KLR Energy Acquisition

$10.40

-0.02 (-0.19%)

17:29
04/23/17
04/23
17:29
04/23/17
17:29
Conference/Events
KLR Energy Acquisition to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

, BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

17:23
04/23/17
04/23
17:23
04/23/17
17:23
Hot Stocks
BD sees forming third business segment, says Bard CEO to join board »

Commenting on its…

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

, BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

17:20
04/23/17
04/23
17:20
04/23/17
17:20
Hot Stocks
BD sees high single-digit EPS accretion in FY19 »

"This financially…

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

, BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

17:18
04/23/17
04/23
17:18
04/23/17
17:18
Hot Stocks
Becton Dickinson says expects to continue buyback suspension »

"BD expects to…

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

, BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

17:16
04/23/17
04/23
17:16
04/23/17
17:16
Hot Stocks
Becton Dickinson to acquire C.R. Bard in $24B cash and stock deal »

BD (BDX) and C. R. Bard…

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

, BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

17:10
04/23/17
04/23
17:10
04/23/17
17:10
Hot Stocks
Breaking Hot Stocks news story on Becton Dickinson, C.R. Bard »

Becton Dickinson to…

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

CS

Credit Suisse

$14.45

-0.09 (-0.62%)

17:07
04/23/17
04/23
17:07
04/23/17
17:07
Periodicals
Credit Suisse to determine capital raise plan after annual meeting, Reuters says »

Credit Suisse will make a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$142.27

-0.17 (-0.12%)

17:04
04/23/17
04/23
17:04
04/23/17
17:04
Periodicals
Uber CEO ordered iPhone tracking, was scolded by Tim Cook, NYT says »

Beginning in 2014, ride…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

AVID

Avid Technology

$5.11

0.19 (3.86%)

, MSFT

Microsoft

$66.40

0.9 (1.37%)

16:30
04/23/17
04/23
16:30
04/23/17
16:30
Hot Stocks
Avid announces strategic cloud alliance with Microsoft »

Avid (AVID) announced it…

AVID

Avid Technology

$5.11

0.19 (3.86%)

MSFT

Microsoft

$66.40

0.9 (1.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 09

    May

  • 09

    May

15:44
04/23/17
04/23
15:44
04/23/17
15:44
Conference/Events
Wolfe Research utilities analyst holds an analyst/industry conference call »

Utilities Analyst…

OA

Orbital ATK

$97.28

-0.65 (-0.66%)

15:32
04/23/17
04/23
15:32
04/23/17
15:32
Hot Stocks
Breaking Hot Stocks news story on Orbital ATK »

Orbital ATK says Cygnus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRV

ContraVir Pharmaceuticals

$1.41

-0.09 (-6.00%)

15:30
04/23/17
04/23
15:30
04/23/17
15:30
Hot Stocks
ContraVir presents data on hepatitis B candidates TXL, CRV431 »

ContraVir Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASPS

Altisource

$24.05

-1.39 (-5.46%)

, NRZ

New Residential

$16.34

-0.05 (-0.31%)

15:30
04/23/17
04/23
15:30
04/23/17
15:30
Conference/Events
Piper Jaffray specialty finance analyst holds analyst/industry conference call »

Regional Banks &…

ASPS

Altisource

$24.05

-1.39 (-5.46%)

NRZ

New Residential

$16.34

-0.05 (-0.31%)

OCN

Ocwen

$2.42

-0.07 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 03

    May

  • 24

    May

MRK

Merck

$61.89

-0.66 (-1.06%)

15:27
04/23/17
04/23
15:27
04/23/17
15:27
Hot Stocks
Merck reports new Phase 2 MK-3682B data »

Merck announced the first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 07

    May

  • 10

    May

  • 27

    May

  • 09

    Jun

  • 14

    Jun

ABUS

Arbutus Biopharma

15:10
04/23/17
04/23
15:10
04/23/17
15:10
Hot Stocks
Arbutus reports ARB-1467 study data, plans additional trial in 2H »

Arbutus Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 26

    Apr

ACHN

Achillion

$3.64

-0.02 (-0.55%)

, JNJ

Johnson & Johnson

$121.76

-0.11 (-0.09%)

15:05
04/23/17
04/23
15:05
04/23/17
15:05
Hot Stocks
Achillion reports updated data from Phase 2 JNJ-4178 study »

Achillion Pharmaceuticals…

ACHN

Achillion

$3.64

-0.02 (-0.55%)

JNJ

Johnson & Johnson

$121.76

-0.11 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 06

    Jun

BMY

Bristol-Myers

$53.48

0.04 (0.07%)

14:59
04/23/17
04/23
14:59
04/23/17
14:59
Hot Stocks
Bristol-Myers says '036 NASH study meets primary endpoint »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 03

    May

  • 06

    Jun

14:52
04/23/17
04/23
14:52
04/23/17
14:52
General news
Breaking General news story  »

Fillon concedes as Le…

ALBO

Albireo Pharma

$20.66

-0.26 (-1.24%)

14:45
04/23/17
04/23
14:45
04/23/17
14:45
Hot Stocks
Albireo Pharma reports 'promising' A4250 data, sees Phase 3 trial start in 2H »

Albireo Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$88.62

-0.71 (-0.79%)

14:34
04/23/17
04/23
14:34
04/23/17
14:34
Hot Stocks
ShaveLogic says wins summary judgement over Gillette »

ShaveLogic issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

ORIG

Ocean Rig UDW

$0.23

-0.0121 (-5.04%)

14:30
04/23/17
04/23
14:30
04/23/17
14:30
Hot Stocks
Ocean Rig UDW extends Drill Rigs early consent deadline »

Ocean Rig UDW announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.